VEGFA and cancer: JunD reduces tumour angiogenesis by limiting Ras-mediated production of reactive oxygen species (ROS) implicated in the pathophysiology of various diseases, including cancer , regulates genes involved in antioxidant defence and enhances the transcription of VEGF-A, a potent proangiogenic factor [7,9].